Ashutosh Shukla, M.D.
Professor Of Medicine, NF/SG VHS
Department:
MD-NEPHROLOGY
Business Phone:
(352) 273-8821
About Ashutosh Shukla
Clinically, I am a provider in advanced chronic kidney disease, or CKD, kidney failure and end stage kidney disease, or ESKD. I have established models for enhanced patient-centered care for those with CKD to ESKD transition, with special emphasis on the patients who are at the most fragile stage of CKD. My overall goal is to enhance patient-centered approaches that can lead to greater patient satisfaction in medical therapies.
In academic realm, I am a professor of medicine in the University of Florida Division of Nephrology, Hypertension & Renal Transplantation and director of the advanced CKD and Home Dialysis Program. I received my medical degree from Gujarat University in India, received specialized training in internal medicine at University of Arkansas for Medical Sciences and Gujarat University, and received my nephrology trainings from University of Toronto and Maharashtra University of Health Sciences in India. I am board certified in nephrology and internal medicine by the American Board of Internal Medicine.
Finally, I am a staff physician with the VA North Florida/South Georgia Veterans Health System. I serve as the chairperson of the National VA Peritoneal Dialysis Workgroup and the co-chair of the VA Peritoneal Dialysis Choice, Access and Quality Workgroups.
My research is focused in the area of advanced chronic kidney disease, high morbidity and mortality associated with CKD, transition to ESRD, and home dialysis therapies with ongoing projections in translational, clinical and health services research.
Accomplishments
Member, Field Advisory Board
2022-Current
·
VHA Kidney Disease Program Office, Department of Veterans Affairs
Co-Chair, VHA National PD Access Subgroup
2019-Current
·
National Kidney Disease Program, Department of Veterans Affairs
Co-Chair, VHA National PD Quality Subgroup
2019-Current
·
National Kidney Disease Program, Department of Veterans Affairs
Co-Chariman, National PD Choice Subgroup
2019-Current
·
National Kidney Disease Program, Department of Veterans Affairs
Chairperson, National VHA Peritoneal Dialysis Workgroup
2018-Current
·
National Kidney Disease Program, Department of Veterans Affairs
Member, Scientific Medical Review Board
2018-Current
·
VA Clinical and Biomedical Research and Development
Teaching Profile
Courses Taught
2015
BMS6638C Kidney & Urinary Tract
Board Certifications
-
Internal MedicineAmerican Board of Internal Medicine
-
NephrologyAmerican Board of Internal Medicine
Clinical Profile
Specialties
- Nephrology
Areas of Interest
- Chronic kidney disease
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0002-1471-0324
Areas of Interest
- Clinical Trials Design & Analysis
- Cardiovascular Disease
- Clinical and translational science
- Mathematical modeling of dialysis adequacy
- Patient-centered Care
- chronic kidney disease
Publications
2024
Ethics and Terminology for Opting In and Out.
JAMA internal medicine.
184(4):451-452
[DOI] 10.1001/jamainternmed.2023.7060.
[PMID] 38372980.
2023
Barriers to and Strategies for Dietary Adherence: A Qualitative Study Among Hemodialysis/Peritoneal Dialysis Patients and Health Care Providers
Journal of Renal Nutrition.
33(5):682-690
[DOI] 10.1053/j.jrn.2023.06.007.
2023
Basic Requirements for Improving Home Dialysis Utilization: Universal Access to Specialty Nephrology Care and Comprehensive Pre-ESKD Education.
Journal of the American Society of Nephrology : JASN.
34(1):21-25
[DOI] 10.1681/ASN.2022060685.
2023
Electronic Phenotype for Advanced Chronic Kidney Disease in a Veteran Health Care System Clinical Database: Systems-Based Strategy for Model Development and Evaluation
Interactive Journal of Medical Research.
12
[DOI] 10.2196/43384.
[PMID] 37486757.
2023
Needs and Considerations for Standardization of Kidney Disease Education in Patients with Advanced CKD
Clinical Journal of the American Society of Nephrology.
18(9):1234-1243
[DOI] 10.2215/cjn.0000000000000170.
2023
Phenomenology and Physiology of Tacrolimus Induced Tremor
Tremor and Other Hyperkinetic Movements.
13(1)
[DOI] 10.5334/tohm.725.
[PMID] 36818753.
2023
Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
Drugs in R&D.
23(4):301-329
[DOI] 10.1007/s40268-023-00428-4.
[PMID] 37606750.
2023
VA-Based Peritoneal Dialysis Program Feasibility Considerations and Process Outline.
Federal practitioner : for the health care professionals of the VA, DoD, and PHS.
40(4):116-122b
[DOI] 10.12788/fp.0356.
[PMID] 37223661.
2022
A randomized controlled trial to evaluate and assess the effect of comprehensive pre-end stage kidney disease education on home dialysis use in veterans, rationale and design.
BMC nephrology.
23(1)
[DOI] 10.1186/s12882-022-02740-8.
[PMID] 35354430.
2022
Development and validation of an end stage kidney disease awareness survey: Item difficulty and discrimination indices
PLOS ONE.
17(9)
[DOI] 10.1371/journal.pone.0269488.
[PMID] 36083893.
2022
Kidney impairment and outcomes in acute ischaemic stroke.
Internal medicine journal.
53(7):1231-1239
[DOI] 10.1111/imj.15852.
[PMID] 35717661.
2022
Provision of Kidney Disease Education Service Is Associated with Improved Vascular Access Outcomes among US Incident Hemodialysis Patients
Kidney360.
3(1):91-98
[DOI] 10.34067/kid.0004502021.
2022
Supporting Shared Decision-Making and Home Dialysis in End-Stage Kidney Disease
International Journal of Nephrology and Renovascular Disease.
Volume 15:229-237
[DOI] 10.2147/ijnrd.s375347.
2021
Association of early initiation of dialysis with all-cause and cardiovascular mortality: A propensity score weighted analysis of the United States Renal Data System.
Hemodialysis international. International Symposium on Home Hemodialysis.
25(2):188-197
[DOI] 10.1111/hdi.12912.
[PMID] 33644974.
2021
Circulating endothelial cells as predictor of long-term mortality and adverse cardiovascular outcomes in hemodialysis patients.
Seminars in dialysis.
34(2):163-169
[DOI] 10.1111/sdi.12943.
[PMID] 33280176.
2021
Encapsulated Peritoneal Sclerosis Masquerading as an Abdominal Catastrophe in Peritoneal Dialysis Therapy.
Cureus.
13(1)
[DOI] 10.7759/cureus.12934.
[PMID] 33654614.
2021
Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design
American Journal of Nephrology.
52(1):36-44
[DOI] 10.1159/000513567.
2021
Mycobacterium abscessus exit-site infection in peritoneal dialysis patients: should we ever aim to salvage the catheter?
CEN Case Reports.
10(1):12-16
[DOI] 10.1007/s13730-020-00506-5.
[PMID] 32662049.
2021
Pro Re Nata Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity-Matched Cohort Study.
Hypertension (Dallas, Tex. : 1979).
78(2):516-524
[DOI] 10.1161/HYPERTENSIONAHA.121.17279.
[PMID] 34148363.
2021
Simultaneous catheter removal and reinsertion, is it acceptable in M. abscessus exit site infection?
CEN Case Reports.
10(4):483-489
[DOI] 10.1007/s13730-021-00593-y.
[PMID] 33728600.
2021
Utilization of CMS pre-ESRD Kidney Disease Education services and its associations with the home dialysis therapies
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.
41(5):453-462
[DOI] 10.1177/0896860820975586.
[PMID] 33258420.
2020
A Word of Caution in the Use of Hydroxychloroquine in the Elderly COVID-19 Population.
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.).
9(4):374-375
[DOI] 10.1097/APO.0000000000000314.
[PMID] 32740071.
2020
Chloroquine and hydroxychloroquine in the context of COVID-19.
Drugs in context.
9
[DOI] 10.7573/dic.2020-4-5.
[PMID] 32373183.
2020
Clostridioides difficile associated peritonitis in peritoneal dialysis patients – a case series based review of an under-recognized entity with therapeutic challenges.
BMC nephrology.
21(1)
[DOI] 10.1186/s12882-020-01734-8.
[PMID] 32131755.
2020
Home run-results of a chronic kidney disease Telemedicine Patient Education Study.
Clinical kidney journal.
13(5):867-872
[DOI] 10.1093/ckj/sfz096.
[PMID] 33123362.
2020
The journey of remdesivir: from Ebola to COVID-19.
Drugs in context.
9
[DOI] 10.7573/dic.2020-4-14.
[PMID] 32547625.
2019
Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues.
Drugs in context.
8
[DOI] 10.7573/dic.2019-9-1.
[PMID] 31844421.
2019
Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients.
Pain research & management.
2019
[DOI] 10.1155/2019/3865924.
[PMID] 31772694.
2019
What do the US advanced kidney disease patients want? Comprehensive pre-ESRD Patient Education (CPE) and choice of dialysis modality
PLOS ONE.
14(4)
[DOI] 10.1371/journal.pone.0215091.
[PMID] 30964936.
2017
Acquired cystic kidney disease: A benign yet potentially fatal condition
Int J Case Rep Images.
8(8):561-563
[DOI] 10.5348/ijcri-201719-CL-10129.
2017
Effects of a Comprehensive Predialysis Education Program on the Home Dialysis Therapies: A Retrospective Cohort Study.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
37(5):542-547
[DOI] 10.3747/pdi.2016.00270.
[PMID] 28546368.
2017
Tunneled dialysis catheters might receive “permanent resident” status after a while: a case for caution.
Kidney international.
91(5)
[DOI] 10.1016/j.kint.2016.11.011.
[PMID] 28407882.
2015
Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease.
PloS one.
10(9)
[DOI] 10.1371/journal.pone.0139226.
[PMID] 26414017.
2015
Recent advances in understanding the pathogenesis of atherosclerosis in CKD patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
25(2):205-8
[DOI] 10.1053/j.jrn.2014.10.024.
[PMID] 25556310.
2012
Extracorporeal therapy in sepsis: are we there yet?
Kidney international.
81(4):336-8
[DOI] 10.1038/ki.2011.375.
[PMID] 22289793.
2006
Intravenous iron does not affect the rate of decline of residual renal function in patients on peritoneal dialysis.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
22:99-103
[PMID] 16983949.
2006
Outcomes of commercial renal transplantation: a Canadian experience.
Transplantation.
82(9):1130-5
[PMID] 17102761.
2006
Streptococcal PD peritonitis–a 10-year review of one centre’s experience.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association – European Renal Association.
21(12):3545-9
[PMID] 17005523.
2004
Peritoneal dialysis in end-stage renal disease after liver transplantation.
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
20:93-7
[PMID] 15384804.
Grants
Oct 2020
– Sep 2022
VA IPA – Gajapathiraju Chamarthi for Ashutosh Shukla
Role: Other
Funding: US DEPT OF VET AFF GAINESVILLE MED CTR
Apr 2019
– Jun 2019
IPA Elizabeth McRee
Role: Other
Funding: US DEPT OF VET AFF GAINESVILLE MED CTR
Education
Residency – Internal Medicine
2009
·
University of Arkansas
Residency – Nephrology
2006
·
University of Toronto
Medical Degree
1996
·
Gujarat University
Contact Details
Phones:
- Business:
- (352) 273-8821
Addresses:
- Business Mailing:
-
PO Box 100224
GAINESVILLE FL 32610